Style | Citing Format |
---|---|
MLA | Asilian A, et al.. "Comparing the Efficacy of Oral Isotretinoin Alone and in Combination With Desloratadine in Treating Moderate to Severe Acne Vulgaris: A Randomized Clinical Trial." Iranian Journal of Dermatology, vol. 27, no. 3, 2024, pp. 153-159. |
APA | Asilian A, Abedini M, Iraji F, Jahanshahi A (2024). Comparing the Efficacy of Oral Isotretinoin Alone and in Combination With Desloratadine in Treating Moderate to Severe Acne Vulgaris: A Randomized Clinical Trial. Iranian Journal of Dermatology, 27(3), 153-159. |
Chicago | Asilian A, Abedini M, Iraji F, Jahanshahi A. "Comparing the Efficacy of Oral Isotretinoin Alone and in Combination With Desloratadine in Treating Moderate to Severe Acne Vulgaris: A Randomized Clinical Trial." Iranian Journal of Dermatology 27, no. 3 (2024): 153-159. |
Harvard | Asilian A et al. (2024) 'Comparing the Efficacy of Oral Isotretinoin Alone and in Combination With Desloratadine in Treating Moderate to Severe Acne Vulgaris: A Randomized Clinical Trial', Iranian Journal of Dermatology, 27(3), pp. 153-159. |
Vancouver | Asilian A, Abedini M, Iraji F, Jahanshahi A. Comparing the Efficacy of Oral Isotretinoin Alone and in Combination With Desloratadine in Treating Moderate to Severe Acne Vulgaris: A Randomized Clinical Trial. Iranian Journal of Dermatology. 2024;27(3):153-159. |
BibTex | @article{ author = {Asilian A and Abedini M and Iraji F and Jahanshahi A}, title = {Comparing the Efficacy of Oral Isotretinoin Alone and in Combination With Desloratadine in Treating Moderate to Severe Acne Vulgaris: A Randomized Clinical Trial}, journal = {Iranian Journal of Dermatology}, volume = {27}, number = {3}, pages = {153-159}, year = {2024} } |
RIS | TY - JOUR AU - Asilian A AU - Abedini M AU - Iraji F AU - Jahanshahi A TI - Comparing the Efficacy of Oral Isotretinoin Alone and in Combination With Desloratadine in Treating Moderate to Severe Acne Vulgaris: A Randomized Clinical Trial JO - Iranian Journal of Dermatology VL - 27 IS - 3 SP - 153 EP - 159 PY - 2024 ER - |